Your browser doesn't support javascript.
loading
AXIN2-related oligodontia-colorectal cancer syndrome with cleft palate as a possible new feature.
Roht, Laura; Hyldebrandt, Hanne K; Stormorken, Astrid T; Nordgarden, Hilde; Sijmons, Rolf H; Bos, Dennis K; Riegert-Johnson, Douglas; Mantia-Macklin, Sarah; Ilves, Pilvi; Muru, Kai; Wojcik, Monica H; Kahre, Tiina; Õunap, Katrin.
Afiliação
  • Roht L; Department of Clinical Genetics, Genetic and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
  • Hyldebrandt HK; Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
  • Stormorken AT; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
  • Nordgarden H; Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
  • Sijmons RH; Norwegian National Resource Centre for Oral Health in Rare Diagnosis, Lovisenberg Diaconal Hospital, Oslo, Norway.
  • Bos DK; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Riegert-Johnson D; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Mantia-Macklin S; Department of Clinical Genetics and Genomics, Mayo Clinic, Jacksonville, Florida, USA.
  • Ilves P; Department of Clinical Genetics and Genomics, Mayo Clinic, Jacksonville, Florida, USA.
  • Muru K; Department of Radiology, Tartu University Hospital, Tartu, Estonia.
  • Wojcik MH; Department of Clinical Genetics, Genetic and Personalized Medicine Clinic, Tartu University Hospital, Tartu, Estonia.
  • Kahre T; Department of Clinical Genetics, Institute of Clinical Medicine, University of Tartu, Tartu, Estonia.
  • Õunap K; Broad Institute of MIT and Harvard, Massachusetts, Cambridge, USA.
Mol Genet Genomic Med ; 11(6): e2157, 2023 06.
Article em En | MEDLINE | ID: mdl-36860143
ABSTRACT

BACKGROUND:

Pathogenic variants in AXIN2 have been associated with tooth agenesis, colon polyps, and colon cancer. Given the rare nature of this phenotype, we set out to collect additional genotypic and phenotypic information.

METHODS:

Data were collected via a structured questionnaire. Sequencing was performed in these patients mostly due to diagnostic purpose. A little more than half of the AXIN2 variant carriers were identified by NGS; other six were family members.

RESULTS:

Here, we report 13 individuals with a heterozygous AXIN2 pathogenic/likely pathogenic variant who have a variable expression of oligodontia-colorectal cancer syndrome (OMIM 608615) or oligodontia-cancer predisposition syndrome (ORPHA 300576). Three individuals from one family also had cleft palate, which might represent a new clinical feature of AXIN2 phenotype, also given the fact that AXIN2 polymorphisms have been found in association with oral clefting in population studies. AXIN2 has already been added to multigene cancer panel tests; further research should be conducted to determine whether it should be added to cleft lip/palate multigene panels.

CONCLUSION:

More clarity about oligodontia-colorectal cancer syndrome, about the variable expression, and associated cancer risks is needed to improve clinical management and to establish guidelines for surveillance. We collected information about the surveillance that was advised, which might support clinical management of these patients.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenda Labial / Fissura Palatina / Anodontia / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estônia

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fenda Labial / Fissura Palatina / Anodontia / Neoplasias Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estônia